Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

label:3577 (Glytoucan)

Id:42b8cc52-94d1-556f-abb1-4d5bd4dec3f0

Glytoucan:G43549OX

Results found

Linked to

	Label	Description
	label:3577 has canonical residue n-glycan a-l-fucp 15 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:3577 has canonical residue n-glycan b-d-glcpnac 11 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:3577 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000022 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:3577 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000025 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:3577 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000027 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:3577 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000019 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:3577 has glycosequence GLYGEN.GLYCOSEQUENCE:G43549OX-GLYCOSEQ00062996 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:3577 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000024 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:3577 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000055 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:3577 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000002 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:3577 has canonical residue n-glycan a-l-fucp 15

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:3577 has canonical residue n-glycan b-d-glcpnac 11

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:3577 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000022 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:3577 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000025 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:3577 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000027 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:3577 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000019 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:3577 has glycosequence GLYGEN.GLYCOSEQUENCE:G43549OX-GLYCOSEQ00062996 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:3577 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000024 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:3577 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000055 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:3577 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000002 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.